Home > Insider Trading > Filing (0001209191-20-031541)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1478320	Adaptive Biotechnologies Corp	ADPT	Biological Products, (No Disgnostic Substances) (2836)	270907024

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780854	Sharon Benzeno	C/O Adaptive Biotechnologies Corp. Suite 200 Seattle WA 98102	Chief Business Development Off	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-19	60,000	$1.98	60,000	No	4	M	Direct
Common Stock	Acquisiton	2020-05-19	18,750	$6.32	78,750	No	4	M	Direct
Common Stock	Acquisiton	2020-05-19	15,416	$6.27	94,166	No	4	M	Direct
Common Stock	Acquisiton	2020-05-19	78,125	$6.55	172,291	No	4	M	Direct
Common Stock	Acquisiton	2020-05-19	49,479	$6.55	221,770	No	4	M	Direct
Common Stock	Acquisiton	2020-05-19	25,000	$7.27	246,770	No	4	M	Direct
Common Stock	Disposition	2020-05-19	246,770	$40.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-19	60,000	$0.00	60,000	$1.98
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-19	18,750	$0.00	18,750	$6.32
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-19	15,416	$0.00	15,416	$6.27
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-19	78,125	$0.00	78,125	$6.55
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-19	49,479	$0.00	49,479	$6.55
Common Stock	Common Stock (Right to Buy)	Disposition	2020-05-19	25,000	$0.00	25,000	$7.27

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2024-04-13	No	4	M	Direct
1,250	2026-09-16	No	4	M	Direct
4,584	2027-04-25	No	4	M	Direct
45,875	2028-02-07	No	4	M	Direct
75,521	2028-10-01	No	4	M	Direct
50,000	2029-02-07	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020.
The option is vested and fully exercisable.
The options vested with respect to 1/4 of such shares on July 26, 2017, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
The options vested with respect to 1/4 of such shares on April 19, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.